Literature DB >> 24548549

Anti-ictogenic effects of the corticotropin-releasing factor-like peptide in the pentylenetetrazole model of seizure in brain slices.

Anatoly A Mokrushin1.   

Abstract

The present study provides evidence for anti-ictogenic activity of the mystixin 7 (MTX) mini-peptide in the pentylenetetrazole model of seizure. MTX was effective in inhibiting/suppressing ictal- and interictal-like activities over a long period of time (during 60-80min). The peptide's anti-ictogenic effects were concentration- and time-dependent. An enzymatic treatment of MTX was accompanied by a decrease of the frequency pattern of epileptiform discharges, but their total blockade did not occurred. These findings indicate that the MTX mini-peptide has pronounced anti-ictogenic properties.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AMPA; Brain slices; EPSP; Epileptiform discharges; Mystixin; NMDA

Mesh:

Substances:

Year:  2014        PMID: 24548549     DOI: 10.1016/j.eplepsyres.2014.01.002

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  1 in total

1.  Mystixin-7 Peptide Protects Ionotropic Glutamatergic Mechanisms against Glutamate-Induced Excitotoxicity In Vitro.

Authors:  Anatoly A Mokrushin
Journal:  Int J Pept       Date:  2016-07-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.